Daniel Pharand, CA

Principal

Mr. Pharand is a Chartered accountant with over 25 years of experience in the pharmaceutical, biotech and life sciences industries where he has a proven track record as a portfolio manager. He serves as a Principal of Cato BioVentures and as Chief Financial Officer of Cato Research. Mr. Pharand was the Chief Financial Officer of Pharmacia Canada and of Pharmacia KK (Japan). He subsequently became an entrepreneur with a successful Canadian distribution company of innovative pedicular screws systems in orthopaedic therapies. Mr Pharand later was involved in the Biotech Venture with Innovatech Grand Montreal over his 5 years as Portfolio Manager. Mr. Pharand has also acted as a director and has served on various board committees for more than 30 publicly traded or life sciences corporations, including Corautus Genetics Inc. (NASDAQ : VEGF), Bio 1 Inc. (now TSX-V : ARU), LAB International Inc. (TSX : LAB) and Mistral Pharma Inc. (TSX-V: MPI).